No Picture
News

Alamar Biosciences Raises $128 Million in Oversubscribed Series C Financing to Accelerate Commercialization of its Proteomics Platform

Financing led by Sands Capital brings total capital raised to nearly $250 million. FREMONT, Calif., Feb. 26, 2024 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced […]